secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYRIAD GENETICS INC (MYGN)
CIK:        0000899923
Form:       8-K
Filed at:   2022-06-02T23:59:59+00:00
Accession:  0000899923-22-000085
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myriad Genetics names Natalie Munk principal accounting officer; shareholders OK ESPP expansion
--------------------------------------------------------------------------------

- Natalie Munk (CAO since July 2020) designated as principal accounting officer; Bryan Riggsbee remains CFO.
- Shareholders approved amended ESPP, increasing authorized shares by 2M and extending term to November 2032.
- Directors Diaz, Dreismann, and Reiten elected to 2025 terms; each received >66M votes in favor.
- Ernst & Young ratified as independent auditor for FY2022 with 71.1M votes for (3.4M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899923/000089992322000085/0000899923-22-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899923/000089992322000085/mygn-20220602.htm
  HTML page:      https://secwatch.observer/filing/0000899923-22-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer